
Christopher R. Stone
Examiner (ID: 10415, Phone: (571)270-3494 , Office: P/1628 )
| Most Active Art Unit | 1628 |
| Art Unit(s) | 1609, 1614, 1628, 4173 |
| Total Applications | 750 |
| Issued Applications | 250 |
| Pending Applications | 42 |
| Abandoned Applications | 457 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4860497
[patent_doc_number] => 20080269347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-30
[patent_title] => 'EPINEPHRINE FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 11/864234
[patent_app_country] => US
[patent_app_date] => 2007-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 8531
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0269/20080269347.pdf
[firstpage_image] =>[orig_patent_app_number] => 11864234
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/864234 | EPINEPHRINE FORMULATIONS | Sep 27, 2007 | Abandoned |
Array
(
[id] => 4834024
[patent_doc_number] => 20080132571
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-06-05
[patent_title] => 'Nutrient Sensor'
[patent_app_type] => utility
[patent_app_number] => 11/862081
[patent_app_country] => US
[patent_app_date] => 2007-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12945
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0132/20080132571.pdf
[firstpage_image] =>[orig_patent_app_number] => 11862081
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/862081 | Nutrient Sensor | Sep 25, 2007 | Abandoned |
Array
(
[id] => 4760023
[patent_doc_number] => 20080312249
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-12-18
[patent_title] => 'KMUP-1 CAPABLE OF TREATING HYPERTENSION'
[patent_app_type] => utility
[patent_app_number] => 11/857483
[patent_app_country] => US
[patent_app_date] => 2007-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 3786
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0312/20080312249.pdf
[firstpage_image] =>[orig_patent_app_number] => 11857483
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/857483 | KMUP-1 CAPABLE OF TREATING HYPERTENSION | Sep 18, 2007 | Abandoned |
Array
(
[id] => 5474423
[patent_doc_number] => 20090247589
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-01
[patent_title] => 'Monocarboxylates for modifying macrophage function'
[patent_app_type] => utility
[patent_app_number] => 12/310971
[patent_app_country] => US
[patent_app_date] => 2007-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3368
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20090247589.pdf
[firstpage_image] =>[orig_patent_app_number] => 12310971
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310971 | Monocarboxylates for modifying macrophage function | Sep 11, 2007 | Abandoned |
Array
(
[id] => 8398436
[patent_doc_number] => 08268817
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-09-18
[patent_title] => 'Substituted oxazole ketone modulators of fatty acid amide hydrolase'
[patent_app_type] => utility
[patent_app_number] => 12/310747
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18263
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12310747
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310747 | Substituted oxazole ketone modulators of fatty acid amide hydrolase | Sep 6, 2007 | Issued |
Array
(
[id] => 6613253
[patent_doc_number] => 20100310455
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-12-09
[patent_title] => 'Heterocyclic Ligands for Integrin Imaging and Therapy'
[patent_app_type] => utility
[patent_app_number] => 12/440219
[patent_app_country] => US
[patent_app_date] => 2007-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 19288
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0310/20100310455.pdf
[firstpage_image] =>[orig_patent_app_number] => 12440219
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/440219 | Heterocyclic ligands for integrin imaging and therapy | Sep 6, 2007 | Issued |
Array
(
[id] => 7535245
[patent_doc_number] => 08048871
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-11-01
[patent_title] => 'Compositions and methods for inhibiting cytochrome P450'
[patent_app_type] => utility
[patent_app_number] => 11/841157
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 1
[patent_no_of_words] => 18919
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 257
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/048/08048871.pdf
[firstpage_image] =>[orig_patent_app_number] => 11841157
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/841157 | Compositions and methods for inhibiting cytochrome P450 | Aug 19, 2007 | Issued |
Array
(
[id] => 8063523
[patent_doc_number] => 20110245262
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/310299
[patent_app_country] => US
[patent_app_date] => 2007-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 40092
[patent_no_of_claims] => 100
[patent_no_of_ind_claims] => 36
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0245/20110245262.pdf
[firstpage_image] =>[orig_patent_app_number] => 12310299
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/310299 | Compounds for treating proliferative disorders | Aug 19, 2007 | Issued |
Array
(
[id] => 5465778
[patent_doc_number] => 20090325978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'STABLE LYOPHILIZED PREPARATION'
[patent_app_type] => utility
[patent_app_number] => 12/375132
[patent_app_country] => US
[patent_app_date] => 2007-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9844
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0325/20090325978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12375132
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/375132 | STABLE LYOPHILIZED PREPARATION | Aug 12, 2007 | Abandoned |
Array
(
[id] => 6583900
[patent_doc_number] => 20100291236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-18
[patent_title] => 'OSMIUM COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 12/377051
[patent_app_country] => US
[patent_app_date] => 2007-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 17730
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20100291236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12377051
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/377051 | OSMIUM COMPOUNDS | Aug 9, 2007 | Abandoned |
Array
(
[id] => 6432007
[patent_doc_number] => 20100152180
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => '4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)'
[patent_app_type] => utility
[patent_app_number] => 12/376613
[patent_app_country] => US
[patent_app_date] => 2007-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21933
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20100152180.pdf
[firstpage_image] =>[orig_patent_app_number] => 12376613
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/376613 | 4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP) | Aug 5, 2007 | Abandoned |
Array
(
[id] => 4734430
[patent_doc_number] => 20080051410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-28
[patent_title] => 'Protein Kinase Targeted Therapeutics'
[patent_app_type] => utility
[patent_app_number] => 11/833152
[patent_app_country] => US
[patent_app_date] => 2007-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8562
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20080051410.pdf
[firstpage_image] =>[orig_patent_app_number] => 11833152
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/833152 | Protein Kinase Targeted Therapeutics | Aug 1, 2007 | Abandoned |
Array
(
[id] => 6596554
[patent_doc_number] => 20100048609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-25
[patent_title] => 'PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID'
[patent_app_type] => utility
[patent_app_number] => 12/376118
[patent_app_country] => US
[patent_app_date] => 2007-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7633
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0048/20100048609.pdf
[firstpage_image] =>[orig_patent_app_number] => 12376118
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/376118 | PHARMACEUTICAL DOSAGE FORMS FOR (+)-1,4-DIHYDRO-7-[(3S,4S)-3-METHOXY-4-(METHYLAMINO)-1-PYRROLIDINYL]-4-OXO-1-(2-THIAZOLYL)-1,8-NAPHTHYRIDINE-3-CARBOXYLIC ACID | Jul 31, 2007 | Abandoned |
Array
(
[id] => 4687673
[patent_doc_number] => 20080031854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-07
[patent_title] => 'THIOLATED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/776519
[patent_app_country] => US
[patent_app_date] => 2007-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14489
[patent_no_of_claims] => 87
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0031/20080031854.pdf
[firstpage_image] =>[orig_patent_app_number] => 11776519
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/776519 | THIOLATED MACROMOLECULES AND METHODS OF MAKING AND USING THEREOF | Jul 10, 2007 | Abandoned |
Array
(
[id] => 4887685
[patent_doc_number] => 20080262017
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-23
[patent_title] => 'Sugar-Free Storage-Stable Antihistaminic Syrups'
[patent_app_type] => utility
[patent_app_number] => 11/769351
[patent_app_country] => US
[patent_app_date] => 2007-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0262/20080262017.pdf
[firstpage_image] =>[orig_patent_app_number] => 11769351
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/769351 | Sugar-Free Storage-Stable Antihistaminic Syrups | Jun 26, 2007 | Abandoned |
Array
(
[id] => 4916299
[patent_doc_number] => 20080096900
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-04-24
[patent_title] => 'Methods for treating atherosclerosis'
[patent_app_type] => utility
[patent_app_number] => 11/823251
[patent_app_country] => US
[patent_app_date] => 2007-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 24586
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0096/20080096900.pdf
[firstpage_image] =>[orig_patent_app_number] => 11823251
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/823251 | Methods for treating atherosclerosis | Jun 25, 2007 | Abandoned |
Array
(
[id] => 6568857
[patent_doc_number] => 20100234399
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'AGENT FOR OVERCOMING RESISTANCE TO ANTI-CANCER AGENT'
[patent_app_type] => utility
[patent_app_number] => 12/305809
[patent_app_country] => US
[patent_app_date] => 2007-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5023
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0234/20100234399.pdf
[firstpage_image] =>[orig_patent_app_number] => 12305809
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/305809 | AGENT FOR OVERCOMING RESISTANCE TO ANTI-CANCER AGENT | Jun 21, 2007 | Abandoned |
Array
(
[id] => 5398432
[patent_doc_number] => 20090318495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-24
[patent_title] => 'ETHENYL CARBOXAMIDE DERIVATIVES USEFUL AS MICROBIOCIDES'
[patent_app_type] => utility
[patent_app_number] => 12/304177
[patent_app_country] => US
[patent_app_date] => 2007-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19587
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0318/20090318495.pdf
[firstpage_image] =>[orig_patent_app_number] => 12304177
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/304177 | Ethenyl carboxamide derivatives useful as microbiocides | Jun 13, 2007 | Issued |
Array
(
[id] => 4670530
[patent_doc_number] => 20080045590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-02-21
[patent_title] => 'USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR PRODUCING DRUGS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 11/759510
[patent_app_country] => US
[patent_app_date] => 2007-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12846
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20080045590.pdf
[firstpage_image] =>[orig_patent_app_number] => 11759510
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/759510 | USE OF SUBSTITUTED CYCLOPROPANE ACID DERIVATIVES FOR PRODUCING DRUGS FOR USE IN THE TREATMENT OF METABOLIC SYNDROME | Jun 6, 2007 | Abandoned |
Array
(
[id] => 5490078
[patent_doc_number] => 20090291149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'Method for treatment of overfiltering and leaking blebs with sterile talc'
[patent_app_type] => utility
[patent_app_number] => 12/308098
[patent_app_country] => US
[patent_app_date] => 2007-06-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4872
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291149.pdf
[firstpage_image] =>[orig_patent_app_number] => 12308098
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/308098 | Method for treatment of overfiltering and leaking blebs with sterile talc | Jun 6, 2007 | Abandoned |